Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ROVASRO 10mg to CRESTOR 10mg in hypercholesterolemia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hypercholesterolemia

Drugs mentioned

• CRESTOR 10mg (rosuvastatin)
• ROVASRO 10mg (ROVASRO)

Snippet

Sponsor: Yonsei University | Conditions: Hypercholesterolemia, Dyslipidemias | Phase 4 | Status: COMPLETED